Maizel Ari
- SEC CIK
- 0002042289
In the past year, 2 open-market sale filings worth $2.75M and no purchases.
Current role at each company
- AXSM Axsome Therapeutics, Inc.Chief Commercial Officeras of Apr 23, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.75M
- 2 filings
- Net
- −$2.75M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Maizel Ari as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 (view filing) | Apr 22 | 1 day | Maizel AriChief Commercial Officer | SSale | −7.50K | $182.42 | −$1.37M | −100.0%0 after | 10b5-1 |
| Jan 23, 2026 (view filing) | Jan 21 | 2 days | Maizel AriChief Commercial Officer | SSale | −7.50K | $184.44 | −$1.38M | −100.0%0 after | 10b5-1 |